Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer - PubMed (original) (raw)
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer
W Jiang et al. Proc Natl Acad Sci U S A. 1993.
Abstract
We have examined DNA from four human esophageal carcinoma cell lines and 50 primary esophageal carcinomas obtained from China, Italy, and France for amplification of the cyclin D1 gene. We also examined 36 of these 50 carcinomas for expression of the cyclin D1 and retinoblastoma (RB) proteins by immunohistochemistry. We found a 3- to 10-fold amplification of the cyclin D1 gene in 16 of the 50 (32%) tumors and in two of the four cell lines. Cyclin D1 protein was overexpressed in 12 of 13 tumors and the two cell lines that showed gene amplification when compared to normal controls. Studies on RB protein expression indicated that 6 of the 36 (17%) tumor samples examined and one cell line did not show detectable expression of this protein. The tumors and cell lines that had cyclin D1 gene amplification and overexpression exhibited normal levels of expression of RB protein. By contrast, the tumors and cell line that did not appear to express the RB protein did not show amplification of the cyclin D1 gene and expressed only low levels of the cyclin D1 protein (P = 0.03). These results suggest that the inhibitory effect of RB on cell cycle progression can be abrogated during tumor development either by loss of expression of the RB gene or by increased expression of the cyclin D1 gene.
Similar articles
- Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA. Huang L, et al. Mol Carcinog. 1996 Feb;15(2):85-95. doi: 10.1002/(SICI)1098-2744(199602)15:2<85::AID-MC1>3.0.CO;2-Q. Mol Carcinog. 1996. PMID: 8599583 - Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A. Jares P, et al. Am J Pathol. 1996 May;148(5):1591-600. Am J Pathol. 1996. PMID: 8623927 Free PMC article. - Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB. Zhang YJ, et al. Biochem Biophys Res Commun. 1993 Oct 29;196(2):1010-6. doi: 10.1006/bbrc.1993.2350. Biochem Biophys Res Commun. 1993. PMID: 8240318 - [Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer].
Takamura H, Fushida S, Hashimoto T, Yagi M, Miyazaki I. Takamura H, et al. Nihon Rinsho. 1996 Apr;54(4):1043-8. Nihon Rinsho. 1996. PMID: 8920671 Review. Japanese. - Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma.
Frierson HF Jr, Gaffey MJ, Zukerberg LR, Arnold A, Williams ME. Frierson HF Jr, et al. Mod Pathol. 1996 Jul;9(7):725-30. Mod Pathol. 1996. PMID: 8832554 Review.
Cited by
- LncRNA SNHG11 promotes the malignant transformation of human bronchial epithelial cells induced by beryllium sulfate.
Deng W, Sun Z, Chen S, Li G, Liu X, Huang L, Zhang Z. Deng W, et al. Toxicol Res (Camb). 2022 Jun 21;11(4):605-615. doi: 10.1093/toxres/tfac036. eCollection 2022 Aug. Toxicol Res (Camb). 2022. PMID: 36051663 Free PMC article. - 5-HT2B-mediated serotonin activation in enterocytes suppresses colitis-associated cancer initiation and promotes cancer progression.
Mao L, Xin F, Ren J, Xu S, Huang H, Zha X, Wen X, Gu G, Yang G, Cheng Y, Zhang C, Wang W, Liu X. Mao L, et al. Theranostics. 2022 May 9;12(8):3928-3945. doi: 10.7150/thno.70762. eCollection 2022. Theranostics. 2022. PMID: 35664068 Free PMC article. - miR-21 Overexpression Promotes Esophageal Squamous Cell Carcinoma Invasion and Migration by Repressing Tropomyosin 1.
Shen Z, Xu X, Lv L, Dai H, Chen J, Chen B. Shen Z, et al. Gastroenterol Res Pract. 2020 Oct 28;2020:6478653. doi: 10.1155/2020/6478653. eCollection 2020. Gastroenterol Res Pract. 2020. PMID: 33193757 Free PMC article. - A CRISPR knockout negative screen reveals synergy between CDKs inhibitor and metformin in the treatment of human cancer in vitro and in vivo.
Ma Y, Zhu Q, Liang J, Li Y, Li M, Zhang Y, Wang X, Zeng Y, Jiao Y. Ma Y, et al. Signal Transduct Target Ther. 2020 Aug 19;5(1):152. doi: 10.1038/s41392-020-0203-1. Signal Transduct Target Ther. 2020. PMID: 32811807 Free PMC article. - CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
Qi Y, Wang D, Huang W, Wang B, Huang D, Xiong F, Chen X, Chen Y. Qi Y, et al. J Exp Clin Cancer Res. 2019 Oct 7;38(1):413. doi: 10.1186/s13046-019-1415-5. J Exp Clin Cancer Res. 2019. PMID: 31590696 Free PMC article.
References
- Cell. 1991 Sep 20;66(6):1197-206 - PubMed
- Cell. 1991 May 17;65(4):691-9 - PubMed
- Oncogene. 1991 Oct;6(10):1779-84 - PubMed
- Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9638-42 - PubMed
- Science. 1991 Nov 22;254(5035):1138-46 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials